4.7 Article

Class II-targeted antigen is superior to CD40-targeted antigen at stimulating humoral responses in vivo

Journal

INTERNATIONAL IMMUNOPHARMACOLOGY
Volume 1, Issue 2, Pages 265-275

Publisher

ELSEVIER SCIENCE BV
DOI: 10.1016/S1567-5769(00)00032-1

Keywords

class II; targeted antigen; dendritic cells; CD40

Funding

  1. NIA NIH HHS [AG14782] Funding Source: Medline

Ask authors/readers for more resources

We examined the efficacy of using monoclonal antibodies to target antigen (avidin) to different surface molecules expressed on antigen presenting cells (APC). In particular, we targeted CD40 to test whether the adjuvant properties of CD40 signaling combined with targeted antigen would result in enhanced serologic responses. We targeted avidin to class II as a positive control and to CD11c as a negative control. These surface proteins represent an ensemble of surface molecules that signal upon ligation and that are expressed on professional APC, in particular dendritic cells (DC). We observed that targeting class II molecules on APC was superior to targeting CD40, or CD11c. However, CD40 and CB11c could function as targets for antigen bound monoclonal antibodies under certain conditions. Interestingly, inclusion of anti-CD40 mAb with the targeting anti-class II-targeted antigens negatively affects humoral response, suggesting that CD40 signaling under certain conditions may suppress processing and/or presentation of targeted antigen. (C) 2001 Published by Elsevier Science B.V.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available